Annals of Oncology Advance Access published online on April 22, 2005
Annals of Oncology, doi:10.1093/annonc/mdi186
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 German Centre for Research on Ageing, Heidelberg, Germany;
* To whom correspondence should be addressed. Background: Over the last decades, long-term survival rates have substantially increased for many forms of cancer. However, these improvements have often been detected with substantial delay by traditional methods of survival analyses. Patients and methods: Using data of the population-based Saarland Cancer Registry, 5- and 10-year relative survival rates were derived for patients with 24 common forms of cancer in Saarland/Germany for the years 2000-2002 by period analysis and compared with conventional cohort estimates of 5- and 10-year relative survival rates pertaining to patients diagnosed in 1990-1992. Results: For many forms of cancer, the 2000-2002 period survival estimates were substantially higher than the corresponding estimates for the cohorts of patients diagnosed in 1990-1992. For example, 10-year relative survival rates achieved in 2000-2002 were close to 100% for patients with testis and thyroid cancer, >85% for patients with melanomas of the skin, Conclusions: Survival expectations of patients diagnosed with cancer at the beginning of the third millenium are substantially higher than previously available survival statistics have suggested.
Received November 11, 2004
Accepted January 12, 2005
Original article
Long-term survival of cancer patients in Germany achieved by the beginning of the third millenium
2 Saarland Cancer Registry, Saarbrücken, Germany
H. Brenner, E-mail: Brenner{at}dzfa.uni-heidelberg.de
Abstract 
80% for patients with endometrial cancer and prostate cancer, close to 70% for patients with breast cancer and kidney cancer, and close to 60% for patients with colon cancer and lymphomas.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Brenner and T. Hakulinen Maximizing the Benefits of Model-Based Period Analysis of Cancer Patient Survival Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1675 - 1681. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Gondos, B Holleczek, V Arndt, C Stegmaier, H Ziegler, and H Brenner Trends in population-based cancer survival in Germany: to what extent does progress reach older patients? Ann. Onc., July 1, 2007; 18(7): 1253 - 1259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Brenner and T. Hakulinen Up-to-date and Precise Estimates of Cancer Patient Survival: Model-based Period Analysis Am. J. Epidemiol., October 1, 2006; 164(7): 689 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Brenner and T. Hakulinen Up-to-Date Estimates of Cancer Patient Survival Even with Common Latency in Cancer Registration. Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1727 - 1732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Houterman, M. L. G. Janssen-Heijnen, L. V. van de Poll-Franse, H. Brenner, and J. W. W. Coebergh Higher long-term cancer survival rates in southeastern Netherlands using up-to-date period analysis Ann. Onc., April 1, 2006; 17(4): 709 - 712. [Abstract] [Full Text] [PDF]
|
|